Therapeutic Research Center CEO and leadership

Dedicated, decisive, and detail oriented Chief Fnancial Officer with proven skills, accomplishments, and experience leading all financial functions including debt consolidations and mergers and acquisitions. Motivational leader and active team participant that manages multiple responsibilities simultaneously in a fast paced, time sensitive environment. Effective communication skills and ability to develop trusting relationships through integrity, professional character, and financial expertise. Technically proficient in working with auditors, investment bankers, commercial banks, corporate boards, and regulatory authorities as a member of the executive management team. C level executive with 30+ years of experience in various industries with several high growth, dynamic, entrepreneurial companies. Demonstrated proficiency in strategic leadership, planning, budgeting, and performance management. Successful P&L management focused on revenue growth, margin and profit improvement, and cost reduction initiatives. M&A experience includes direct hands on involvement in the successful sale of four privately held companies to large publicly held companies including: 2014 - Cytosport Holdings, Inc. to Hormel Foods Corporation (HRL - NYSE), 2006 - Century Theatres, Inc. to Cinemark Holdings, Inc. (CNK - NYSE), 1997 - Oclassen Pharmaceuticals, Inc. to Watson Pharmaceuticals, Inc. (WPI - NYSE) now Activis Inc. (ACT - NYSE), and 1994 - Kransco to Mattel, Inc. (MAT - Nasdaq).